510(k) device
Socrates Aspiration System (Socrates 70 Aspiration Catheter)
Scientia Vascular, Inc. · Catheter, Thrombus Retriever (NRY, Class II) · First FDA decision Sep 20, 2023, newest Jul 16, 2026Acute ischemic stroke
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Socrates Aspiration"
MAUDE reports
0
Brand "Socrates Aspiration", since 2015
PubMed studies
0
Mentioning "Socrates Aspiration"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Socrates Aspiration System (Socrates 70 Aspiration Catheter)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K260002 · Decided Jul 16, 2026 · 195 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K223913 · Decided Sep 20, 2023 · 265 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Socrates Aspiration", any status and sponsor, newest update first.
No registered device study names "Socrates Aspiration".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Socrates Aspiration", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NRY
6,841 reports: 3,541 malfunction, 2,671 injury, 627 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1234-2025 · Started Jan 2, 2025 · Posted by FDA Feb 26, 2025
Reason given: Due to manufacturing non-conformance that resulted in channels in the seal on the packaging pouch. As a result, this could potential create a breach in the sterile barrier.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Thrombus Retriever (NRY)
Published research
The most relevant PubMed records for "Socrates Aspiration"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NRY.
- Penumbra System (Thunderbolt Aspiration Tubing)Penumbra, Inc. · 510(k) 2026
- Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2024
- Route 92 Medical Full Length 046 Reperfusion System and Aspiration Tubing SetRoute 92 Medical, Inc. · 510(k) 2026
- EMBOTRAP III Revascularization DeviceNeuravi Limited · 510(k) 2025
- Solitaire Platinum Revascularization Device, 6x40 mmMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2017
- Merci Retriever, Models 90050, 90060, 90066, 90070, 90110, 90111, 90112, 90113Concentric Medical, Inc. · 510(k) 2009
- Modified Merci Retriever, Model 90060Concentric Medical, Inc. · 510(k) 2007
- Millipede SystemPerfuze, Ltd. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.